
About Enzene Biosciences
Enzene Biosciences is a Healthcare company based in Pune (India) founded in 2006. Company specializing in development of Biosimilars. Enzene Biosciences has raised $50 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 1,023 employees. Its website enzene.com draws about 22 thousand monthly visits. Its Indian entity Enzene Biosciences Limited reported revenue of ₹468 Cr. Enzene Biosciences offers products and services including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.
Company details
Enzene Biosciences was founded in 2006 in Pune, India, as a subsidiary of Alkem Laboratories Limited. Operations are centered on biosimilars in the biotechnology sector, with platforms established in molecular biology, protein expression, and fermentation for microbial, insect, and mammalian cells. Expertise includes upstream and downstream process development, bio-analytics for peptides and proteins, cell-based bioassays, and peptide synthesis via solution and solid-state methods.
- Headquarters Pune, India
- Employees 1,023
- SectorsHealthcare
- Website enzene.com
- Social LinkedIn X YouTube
- Legal Name Enzene Biosciences Limited
- Date of Incorporation 28 Aug, 2006
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹468 Cr
FY 2026 · +33% YoY
- Net Loss-₹150 Cr
FY 2026 · -31% margin
- EBITDA-₹43.30 Cr
FY 2026 · -9% margin
- Total Equity Funding$50M (USD)
in 1 rounds
- Latest Funding Round$50M (USD), Series C
Jan 2023
- InvestorsEight Roads Ventures
& 1 more
- Employee Count1,023
Associated legal entities of Enzene Biosciences
Enzene Biosciences is associated with 2 registered companies on The Company Check; the primary company is Enzene Biosciences Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Enzene Biosciences Limited CIN U24232PN2006PLC165610 | Active | 28 Aug 2006 | Pune, Maharashtra | ₹468 Cr | 665 | 12 | View details |
| Alkem Laboratories Limited Listed CIN L00305MH1973PLC174201 | Active | 08 Aug 1973 | Mumbai, Maharashtra | ₹15,310 Cr | 18,498 | 13 | View details |
Products & Services of Enzene Biosciences
Enzene Biosciences offers a comprehensive portfolio of products and services, including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services.
Continuous bioprocess for efficient biologics production and cost reduction
Solutions for target identification and antibody engineering processes
Support for cell line engineering and formulation development
Tech transfer and scale-up for biologics manufacturing
Apps and channels of Enzene Biosciences
its YouTube channel Enzene has 188 subscribers and 23 videos.
Videos from Enzene Biosciences
The most watched videos on Enzene Biosciences's YouTube channel, Enzene (188 subscribers). Click a video to play it here.
More on Enzene.
Funding Insights of Enzene Biosciences
Enzene Biosciences has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series C round of $50 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50M
- Total Rounds 1
- Last Round Series C — $50M
- First Round $50M
(Jan 2023)
- Investors Count 2
All 1 funding rounds of Enzene Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $50M | Series C | – | – |
2 investors in total: 2 institutional.
Investors in Enzene Biosciences
Enzene Biosciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com |
Investor details for Enzene Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Enzene Biosciences Limited (Enzene Biosciences)
Enzene Biosciences Limited is the primary company behind Enzene Biosciences. The boards of the 2 registered companies of Enzene Biosciences currently have 17 directors; the longest-serving is Basudeo Narayan Singh, appointed in 1973. 36 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Basudeo Narayan Singh DIN 00760310 | Whole-time director | 08 Aug 1973 | 53 yrs 3 mo | Alkem Laboratories Limited |
| Mritunjay Kumar Singh DIN 00881412 | Whole-time director | 11 Feb 2008 | 18 yrs 9 mo | Alkem Laboratories Limited, Enzene Biosciences Limited |
| Sandeep Singh DIN 01277984 | Managing Director | 09 Aug 2013 | 13 yrs 3 mo | Alkem Laboratories Limited, Enzene Biosciences Limited |
| Himanshu Shashikant Gadgil DIN 07548149 | Whole-time director | 09 Feb 2017 | 9 yrs 9 mo | Enzene Biosciences Limited |
| Sarvesh Singh DIN 01278229 | Whole-time director | 11 Nov 2019 | 7 yrs | Alkem Laboratories Limited |
| Narendra Kumar Aneja DIN 00124302 | Director | 16 Mar 2020 | 6 yrs 8 mo | Alkem Laboratories Limited, Enzene Biosciences Limited |
| Madhurima Singh DIN 09137323 | Whole-time director | 20 Dec 2021 | 4 yrs 11 mo | Alkem Laboratories Limited |
| Sangeeta Kapil Jit Singh DIN 06920906 | Director | 02 Aug 2022 | 4 yrs 3 mo | Enzene Biosciences Limited |
| Sujjain Suresh Talwar DIN 01756539 | Director | 05 Aug 2022 | 4 yrs 3 mo | Alkem Laboratories Limited |
| Srinivas Balmiki Prasad Singh DIN 06744441 | Whole-time director | 14 Sep 2022 | 4 yrs 2 mo | Alkem Laboratories Limited, Enzene Biosciences Limited |
| Prem Pavoor DIN 05268309 | Director | 30 Jan 2023 | 3 yrs 9 mo | Enzene Biosciences Limited |
| Rajeev Kher DIN 01192524 | Director | 09 Aug 2024 | 2 yrs 3 mo | Alkem Laboratories Limited |
| Aniruddha Singh DIN 09137325 | Director | 07 Mar 2025 | 1 yr 8 mo | Enzene Biosciences Limited |
| Laxmana Ranjal Shenoy DIN 00074761 | Director | 13 Jul 2025 | 1 yr 4 mo | Alkem Laboratories Limited |
| Neela Bhattacherjee DIN 01912483 | Director | 13 Jul 2025 | 1 yr 4 mo | Alkem Laboratories Limited |
| Diwakar Gupta DIN 01274552 | Director | 13 Jul 2025 | 1 yr 4 mo | Alkem Laboratories Limited |
| Ketan Mahendra Patel DIN 07229648 | Director | 22 May 2026 | 6 mo | Enzene Biosciences Limited |
People of Enzene Biosciences
82 people are tracked at Enzene Biosciences (30 in leadership, 6 in board & advisors, 46 in team); the tracked headcount is 1,023.
| Name | Role | Group |
|---|---|---|
Rebekah Clark | Director Of Sales Operations | Leadership |
Arindam Chakraborty | General Manager | Leadership |
Royston Pinto | Director Of Marketing And Public Relations | Leadership |
Ramesh Kuril | Sr. General Manager & Head Regulatory Affairs | Leadership |
Neel Ambani | Chief Financial Officer | Leadership |
| CEO | Leadership | |
Wouter Huizinga | Executive Director Sales & Business Development | Leadership |
Sushil Momaya | General Manager, Sales And Business Development | Leadership |
Pankaj Gour | Sr. General Manager & Head Of MSAT | Leadership |
Norm Stoffregen | Senior Vice President & Site Head | Leadership |
Russell Miller | Vice President Global Sales & Marketing | Leadership |
Anant Suri | Director Business Development- Products | Leadership |
Lourdes Gonzalez-Novo | Chief Commercial Officer (cco) | Leadership |
Shilpa Gadgil | Vice President | Leadership |
Dharmesh Chaudhari | Senior Manager QA And Site Head | Leadership |
Kamalamani Palle | Head - IT | Leadership |
Harsh Vahia | Assistant General Manager - Business Finance | Leadership |
Yukhti Yachha | Senior Director, Global Business Development- Biologics | Leadership |
Veena Pai Raiker | Senior General Manager And Head Of Project Management | Leadership |
Jin Kim | Executive Director Of Business Development | Leadership |
62 more people are available in the full profile.
Complete people profiles for Enzene Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Enzene Biosciences
Figures of Enzene Biosciences Limited, the primary company behind Enzene Biosciences, for FY 2026. Revenue was ₹468 Cr (+33% year on year). Net loss was -₹150 Cr (-31% margin). EBITDA was -₹43.30 Cr (-9% margin). Revenue has grown at a compounded annual rate of +50% over three years and 0% over five years.
- ₹468 CrRevenue · FY 2026 · +33% YoY
- -₹150 CrNet loss · -31% margin
- -₹43.30 CrEBITDA · -9% margin
- ₹58.45 CrPaid-up capital
- 665Employees (provident fund records)
- +50%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Enzene Biosciences Limited are on its company page.
Detailed financial statements for Enzene Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Enzene Biosciences
2 dated milestones of Enzene Biosciences across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Enzene Biosciences is founded.
- Funding First funding round of $50.0M.
Web traffic of Enzene Biosciences
The website of Enzene Biosciences (enzene.com) receives about 22.2K visits a month.
- Monthly visits22.2K
▼ 22% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Enzene Biosciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Enzene Biosciences
Complete news archive for Enzene Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzene Biosciences
Enzene Biosciences was founded in 2006 and raised its 1st funding round 17 years after it was founded.
Enzene Biosciences is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Enzene Biosciences is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Series C of $50M, raised on Jan 2023.
Enzene Biosciences has 1,023 employees.
The primary company behind Enzene Biosciences, Enzene Biosciences Limited, reported revenue of ₹468 Cr for FY 2026, up 33% year on year.
Enzene Biosciences was founded in 2006 in Pune, India, as a subsidiary of Alkem Laboratories Limited. Operations are centered on biosimilars in the biotechnology sector, with platforms established in molecular biology, protein expression, and fermentation for microbial, insect, and mammalian cells. Expertise includes upstream and downstream process development, bio-analytics for peptides and proteins, cell-based bioassays, and peptide synthesis via solution and solid-state methods.
Enzene Biosciences offers EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services.
Enzene Biosciences has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.
Enzene Biosciences is associated with 2 legal entities: Enzene Biosciences Limited, Alkem Laboratories Limited.
The legal entities of Enzene Biosciences currently have 20 directors, including Manish Narang, Sujjain Suresh Talwar, Srinivas Balmiki Prasad Singh and others.
